IDE892 & IDE397A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Sponsor:

IDEAYA Biosciences

Code:

NCT07277413

Conditions

NSCLC Adenocarcinoma

Gastroesophageal Cancer (GC)

Gastric Adenocarcinoma

Adenocarcinoma of Esophagus

Squamous Cell Car. - Esophagus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IDE892

IDE397

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-02. This information was provided to ClinicalTrials.gov by IDEAYA Biosciences on 2026-08-05.